dataset_id,type_of_cancer,PMID,Title,dataset_url,publication_url,PMCID,Year,Month,Day
acbc_mskcc_2015,acbc,26095796,Genomic landscape of adenoid cystic carcinoma of the breast.,https://cbioportal-datahub.s3.amazonaws.com/acbc_mskcc_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26095796,PMC4676955,2015,Oct,
acc_2019,acyc,31483290,Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/acc_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31483290,PMC6763222,2019,Oct,1.0
acyc_fmi_2014,acyc,24418857,Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.,https://cbioportal-datahub.s3.amazonaws.com/acyc_fmi_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24418857,,2014,Feb,
acyc_jhu_2016,acyc,26862087,Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/acyc_jhu_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26862087,PMC4818686,2016,Apr,
acyc_mda_2015,acyc,26631609,Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.,https://cbioportal-datahub.s3.amazonaws.com/acyc_mda_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26631609,PMC4807116,2016,Feb,1.0
acyc_mgh_2016,acyc,26829750,An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/acyc_mgh_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26829750,PMC4767593,2016,Mar,
acyc_mskcc_2013,acyc,23685749,The mutational landscape of adenoid cystic carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/acyc_mskcc_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23685749,PMC3708595,2013,Jul,
acyc_sanger_2013,acyc,23778141,Whole exome sequencing of adenoid cystic carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/acyc_sanger_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23778141,PMC3999050,2013,Jul,
all_stjude_2013,myeloid,23334668,The genomic landscape of hypodiploid acute lymphoblastic leukemia.,https://cbioportal-datahub.s3.amazonaws.com/all_stjude_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23334668,PMC3919793,2013,Mar,
all_stjude_2015,bll,25730765,The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.,https://cbioportal-datahub.s3.amazonaws.com/all_stjude_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25730765,PMC4553269,2015,Apr,
all_stjude_2016,bll,27776115,Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.,https://cbioportal-datahub.s3.amazonaws.com/all_stjude_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/27776115,PMC5144107,2016,Dec,
aml_ohsu_2018,aml,30333627,Functional genomic landscape of acute myeloid leukaemia.,https://cbioportal-datahub.s3.amazonaws.com/aml_ohsu_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30333627,PMC6280667,2018,Oct,
aml_ohsu_2022,aml,35868306,Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.,https://cbioportal-datahub.s3.amazonaws.com/aml_ohsu_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35868306,PMC9378589,2022,Aug,8.0
ampca_bcm_2016,ampca,26804919,Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.,https://cbioportal-datahub.s3.amazonaws.com/ampca_bcm_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26804919,PMC4982376,2016,Feb,2.0
angs_project_painter_2018,angs,32042194,The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.,https://cbioportal-datahub.s3.amazonaws.com/angs_project_painter_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32042194,,2020,Feb,
appendiceal_msk_2022,apad,36493333,Molecular Classification of Appendiceal Adenocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/appendiceal_msk_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36493333,PMC10043565,2023,Mar,10.0
asclc_msk_2024,lung,39185963,Chromothripsis-Mediated Small Cell Lung Carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/asclc_msk_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/39185963,PMC11726019,2025,Jan,13.0
bcc_unige_2016,bcc,26950094,Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/bcc_unige_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26950094,,2016,Apr,
bfn_duke_nus_2015,bfn,26437033,Genomic landscapes of breast fibroepithelial tumors.,https://cbioportal-datahub.s3.amazonaws.com/bfn_duke_nus_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26437033,,2015,Nov,
bladder_columbia_msk_2018,bladder,29625057,Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.,https://cbioportal-datahub.s3.amazonaws.com/bladder_columbia_msk_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29625057,PMC5890941,2018,Apr,5.0
bladder_msk_2023,bladder,37682528,Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.,https://cbioportal-datahub.s3.amazonaws.com/bladder_msk_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37682528,PMC11233068,2023,Nov,14.0
blca_bcan_hcrn_2022,blca,36333289,Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.,https://cbioportal-datahub.s3.amazonaws.com/blca_bcan_hcrn_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36333289,PMC9636269,2022,Nov,4.0
blca_bgi,blca,24121792,Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation.,https://cbioportal-datahub.s3.amazonaws.com/blca_bgi.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24121792,PMC7512009,2013,Dec,
blca_cornell_2016,blca,27749842,Clonal evolution of chemotherapy-resistant urothelial carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/blca_cornell_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/27749842,PMC5549141,2016,Dec,
blca_dfarber_mskcc_2014,blca,25096233,Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/blca_dfarber_mskcc_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25096233,PMC4238969,2014,Oct,
blca_msk_tcga_2020,blca,30290956,"Genomic Differences Between ""Primary"" and ""Secondary"" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.",https://cbioportal-datahub.s3.amazonaws.com/blca_msk_tcga_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30290956,PMC6339572,2019,Feb,
blca_mskcc_solit_2012,blca,23897969,Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer.,https://cbioportal-datahub.s3.amazonaws.com/blca_mskcc_solit_2012.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23897969,PMC3753703,2013,Sep,1.0
blca_mskcc_solit_2014,blca,25092538,Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder.,https://cbioportal-datahub.s3.amazonaws.com/blca_mskcc_solit_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25092538,PMC4312739,2015,Feb,
blca_nmibc_2017,blca,28583311,Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.,https://cbioportal-datahub.s3.amazonaws.com/blca_nmibc_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28583311,PMC6007852,2017,Dec,
blca_plasmacytoid_mskcc_2016,blca,26901067,Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.,https://cbioportal-datahub.s3.amazonaws.com/blca_plasmacytoid_mskcc_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26901067,PMC4827439,2016,Apr,
blca_tcga_pub,blca,24476821,Comprehensive molecular characterization of urothelial bladder carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/blca_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24476821,PMC3962515,2014,Mar,20.0
blca_tcga_pub_2017,blca,28988769,Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.,https://cbioportal-datahub.s3.amazonaws.com/blca_tcga_pub_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28988769,PMC5687509,2017,Oct,19.0
bm_nsclc_mskcc_2023,nsclc,37591896,Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis.,https://cbioportal-datahub.s3.amazonaws.com/bm_nsclc_mskcc_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37591896,PMC10435547,2023,Aug,17.0
bowel_colitis_msk_2022,bowel,36611031,Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers.,https://cbioportal-datahub.s3.amazonaws.com/bowel_colitis_msk_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36611031,PMC9825391,2023,Jan,7.0
braf_msk_archer_2024,mixed,38922339,Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets.,https://cbioportal-datahub.s3.amazonaws.com/braf_msk_archer_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38922339,PMC11371517,2024,Sep,3.0
braf_msk_impact_2024,mixed,38922339,Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets.,https://cbioportal-datahub.s3.amazonaws.com/braf_msk_impact_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38922339,PMC11371517,2024,Sep,3.0
brain_cptac_2020,brain,33242424,Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer.,https://cbioportal-datahub.s3.amazonaws.com/brain_cptac_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33242424,PMC8143193,2020,Dec,23.0
brca_bccrc,brca,22495314,The clonal and mutational evolution spectrum of primary triple-negative breast cancers.,https://cbioportal-datahub.s3.amazonaws.com/brca_bccrc.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22495314,PMC3863681,2012,Apr,4.0
brca_bccrc_xenograft_2014,brca,25470049,Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.,https://cbioportal-datahub.s3.amazonaws.com/brca_bccrc_xenograft_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25470049,PMC4864027,2015,Feb,19.0
brca_broad,brca,22722202,Sequence analysis of mutations and translocations across breast cancer subtypes.,https://cbioportal-datahub.s3.amazonaws.com/brca_broad.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22722202,PMC4148686,2012,Jun,20.0
brca_cptac_2020,brca,33212010,Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.,https://cbioportal-datahub.s3.amazonaws.com/brca_cptac_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33212010,PMC8077737,2020,Nov,25.0
brca_dfci_2020,brca,32404308,The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.,https://cbioportal-datahub.s3.amazonaws.com/brca_dfci_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32404308,PMC8815415,2020,Aug,
brca_fuscc_2020,brca,32719455,Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial.,https://cbioportal-datahub.s3.amazonaws.com/brca_fuscc_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32719455,PMC8027015,2021,Feb,
brca_igr_2015,brca,28027327,Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.,https://cbioportal-datahub.s3.amazonaws.com/brca_igr_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28027327,PMC5189935,2016,Dec,
brca_jup_msk_2020,brca,33263939,Whole-exome sequencing analysis of juvenile papillomatosis and coexisting breast carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/brca_jup_msk_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33263939,PMC7869928,2021,Mar,
brca_mapk_hp_msk_2021,brca,34795269,HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway.,https://cbioportal-datahub.s3.amazonaws.com/brca_mapk_hp_msk_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34795269,PMC8602441,2021,Nov,18.0
brca_mskcc_2019,brca,31552290,PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer.,https://cbioportal-datahub.s3.amazonaws.com/brca_mskcc_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31552290,PMC6757060,2019,,
brca_pareja_msk_2020,brca,32220886,Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma ,https://cbioportal-datahub.s3.amazonaws.com/brca_pareja_msk_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32220886,PMC7367727,2020,Jul,15.0
brca_sanger,brca,22722201,The landscape of cancer genes and mutational processes in breast cancer.,https://cbioportal-datahub.s3.amazonaws.com/brca_sanger.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22722201,PMC3428862,2012,May,16.0
brca_smc_2018,brca,29713003,Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.,https://cbioportal-datahub.s3.amazonaws.com/brca_smc_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29713003,PMC5928087,2018,Apr,30.0
brca_tcga_pub,brca,23000897,Comprehensive molecular portraits of human breast tumours.,https://cbioportal-datahub.s3.amazonaws.com/brca_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23000897,PMC3465532,2012,Oct,4.0
brca_tcga_pub2015,brca,26451490,Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.,https://cbioportal-datahub.s3.amazonaws.com/brca_tcga_pub2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26451490,PMC4603750,2015,Oct,8.0
breast_alpelisib_2020,breast,32864625,Alterations in ,https://cbioportal-datahub.s3.amazonaws.com/breast_alpelisib_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32864625,PMC7450824,2020,Apr,
breast_ink4_msk_2021,breast,34544752,INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors.,https://cbioportal-datahub.s3.amazonaws.com/breast_ink4_msk_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34544752,PMC8831444,2022,Feb,
breast_msk_2018,breast,30205045,The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.,https://cbioportal-datahub.s3.amazonaws.com/breast_msk_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30205045,PMC6327853,2018,Sep,10.0
ccrcc_dfci_2019,ccrcc,29301960,Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/ccrcc_dfci_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29301960,PMC6035749,2018,Feb,16.0
ccrcc_irc_2014,ccrcc,24487277,Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.,https://cbioportal-datahub.s3.amazonaws.com/ccrcc_irc_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24487277,PMC4636053,2014,Mar,
ccrcc_utokyo_2013,ccrcc,23797736,Integrated molecular analysis of clear-cell renal cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/ccrcc_utokyo_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23797736,,2013,Aug,
cellline_ccle_broad,mixed,22460905,The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.,https://cbioportal-datahub.s3.amazonaws.com/cellline_ccle_broad.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22460905,PMC3320027,2012,Mar,28.0
cellline_nci60,mixed,22802077,CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set.,https://cbioportal-datahub.s3.amazonaws.com/cellline_nci60.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22802077,PMC3399763,2012,Jul,15.0
cervix_msk_2023,cervix,37643132,Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.,https://cbioportal-datahub.s3.amazonaws.com/cervix_msk_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37643132,PMC10644000,2023,Nov,14.0
cfdna_msk_2019,mixed,31768066,High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.,https://cbioportal-datahub.s3.amazonaws.com/cfdna_msk_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31768066,PMC7061455,2019,Dec,
chol_icgc_2017,chol,28667006,Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/chol_icgc_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28667006,PMC5628134,2017,Oct,
chol_jhu_2013,chol,24185509,"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.",https://cbioportal-datahub.s3.amazonaws.com/chol_jhu_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24185509,PMC4013720,2013,Dec,
chol_msk_2018,chol,29848569,Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.,https://cbioportal-datahub.s3.amazonaws.com/chol_msk_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29848569,PMC6642361,2018,Sep,1.0
chol_nccs_2013,chol,24185513,Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.,https://cbioportal-datahub.s3.amazonaws.com/chol_nccs_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24185513,,2013,Dec,
chol_nus_2012,chol,22561520,Exome sequencing of liver fluke-associated cholangiocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/chol_nus_2012.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22561520,,2012,May,6.0
cll_broad_2015,cllsll,26466571,Mutations driving CLL and their evolution in progression and relapse.,https://cbioportal-datahub.s3.amazonaws.com/cll_broad_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26466571,PMC4815041,2015,Oct,22.0
cll_broad_2022,cllsll,35927489,Molecular map of chronic lymphocytic leukemia and its impact on outcome.,https://cbioportal-datahub.s3.amazonaws.com/cll_broad_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35927489,PMC10084830,2022,Nov,
cll_iuopa_2015,cllsll,26200345,Non-coding recurrent mutations in chronic lymphocytic leukaemia.,https://cbioportal-datahub.s3.amazonaws.com/cll_iuopa_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26200345,,2015,Oct,22.0
cllsll_icgc_2011,cllsll,22158541,Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.,https://cbioportal-datahub.s3.amazonaws.com/cllsll_icgc_2011.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22158541,,2011,Dec,11.0
coad_caseccc_2015,coad,25583493,Novel recurrently mutated genes in African American colon cancers.,https://cbioportal-datahub.s3.amazonaws.com/coad_caseccc_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25583493,PMC4313860,2015,Jan,27.0
coad_cptac_2019,coad,31031003,Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.,https://cbioportal-datahub.s3.amazonaws.com/coad_cptac_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31031003,PMC6768830,2019,May,2.0
coad_silu_2022,coad,37202560,"An integrated tumor, immune and microbiome atlas of colon cancer.",https://cbioportal-datahub.s3.amazonaws.com/coad_silu_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37202560,PMC10202816,2023,May,
coadread_cass_2020,coadread,32888432,Integrated Omics of Metastatic Colorectal Cancer.,https://cbioportal-datahub.s3.amazonaws.com/coadread_cass_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32888432,,2020,Nov,9.0
coadread_dfci_2016,coadread,27149842,Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/coadread_dfci_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/27149842,PMC4850357,2016,Apr,26.0
coadread_genentech,coadread,22895193,Recurrent R-spondin fusions in colon cancer.,https://cbioportal-datahub.s3.amazonaws.com/coadread_genentech.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22895193,PMC3690621,2012,Aug,30.0
coadread_mskcc,coadread,25164765,Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions.,https://cbioportal-datahub.s3.amazonaws.com/coadread_mskcc.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25164765,PMC4189196,2014,Aug,28.0
coadread_mskresistance_2022,coadread,36355783,Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal Cancer.,https://cbioportal-datahub.s3.amazonaws.com/coadread_mskresistance_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36355783,PMC9827113,2023,Jan,9.0
coadread_tcga_pub,coadread,22810696,Comprehensive molecular characterization of human colon and rectal cancer.,https://cbioportal-datahub.s3.amazonaws.com/coadread_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22810696,PMC3401966,2012,Jul,18.0
crc_apc_impact_2020,coadread,32730818,"Specific Mutations in APC, but Not Alterations in DNA Damage Response, Associate With Outcomes of Patients With Metastatic Colorectal Cancer.",https://cbioportal-datahub.s3.amazonaws.com/crc_apc_impact_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32730818,PMC7680360,2020,Nov,
crc_dd_2022,coadread,35235413,Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer.,https://cbioportal-datahub.s3.amazonaws.com/crc_dd_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35235413,PMC8906458,2022,Mar,
crc_eo_2020,bowel,34405229,A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.,https://cbioportal-datahub.s3.amazonaws.com/crc_eo_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34405229,PMC8634406,2021,Nov,29.0
crc_hta11_htan_2021,coadread,34910928,Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps.,https://cbioportal-datahub.s3.amazonaws.com/crc_hta11_htan_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34910928,PMC8941949,2021,Dec,22.0
crc_msk_2017,coadread,29316426,Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.,https://cbioportal-datahub.s3.amazonaws.com/crc_msk_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29316426,PMC5765991,2018,Jan,8.0
crc_nigerian_2020,coadread,34819518,Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights.,https://cbioportal-datahub.s3.amazonaws.com/crc_nigerian_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34819518,PMC8613248,2021,Nov,24.0
cscc_dfarber_2015,cscc,25589618,Genomic analysis of metastatic cutaneous squamous cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/cscc_dfarber_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25589618,PMC4359951,2015,Mar,15.0
cscc_hgsc_bcm_2014,cscc,25303977,Mutational landscape of aggressive cutaneous squamous cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/cscc_hgsc_bcm_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25303977,PMC4367811,2014,Dec,15.0
cscc_ranson_2022,cscc,35982973,Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/cscc_ranson_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35982973,PMC9379253,2022,,
cscc_ucsf_2021,cscc,34272401,The landscape of driver mutations in cutaneous squamous cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/cscc_ucsf_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34272401,PMC8285521,2021,Jul,16.0
ctcl_columbia_2015,nhl,26551667,The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.,https://cbioportal-datahub.s3.amazonaws.com/ctcl_columbia_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26551667,PMC4878831,2015,Dec,
desm_broad_2015,desm,26343386,Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.,https://cbioportal-datahub.s3.amazonaws.com/desm_broad_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26343386,PMC4589486,2015,Oct,
difg_glass_2019,difg,31748746,Longitudinal molecular trajectories of diffuse glioma in adults.,https://cbioportal-datahub.s3.amazonaws.com/difg_glass_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31748746,PMC6897368,2019,Dec,
difg_msk_2023,difg,37910594,Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma.,https://cbioportal-datahub.s3.amazonaws.com/difg_msk_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37910594,PMC10841595,2024,Jan,5.0
dlbc_broad_2012,nhl,22343534,Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.,https://cbioportal-datahub.s3.amazonaws.com/dlbc_broad_2012.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22343534,PMC3309757,2012,Mar,6.0
dlbcl_dfci_2018,dlbclnos,29713087,Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.,https://cbioportal-datahub.s3.amazonaws.com/dlbcl_dfci_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29713087,PMC6613387,2018,May,
dlbcl_duke_2017,dlbclnos,28985567,Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.,https://cbioportal-datahub.s3.amazonaws.com/dlbcl_duke_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28985567,PMC5659841,2017,Oct,5.0
egc_msk_2017,egc,29122777,Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.,https://cbioportal-datahub.s3.amazonaws.com/egc_msk_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29122777,PMC5813492,2018,Jan,
egc_msk_2023,stomach,37699004,Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer.,https://cbioportal-datahub.s3.amazonaws.com/egc_msk_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37699004,PMC10852615,2024,Feb,8.0
esca_broad,esca,23525077,Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.,https://cbioportal-datahub.s3.amazonaws.com/esca_broad.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23525077,PMC3678719,2013,May,
egc_msk_tp53_ccr_2022,egc,35377946,The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/egc_msk_tp53_ccr_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35377946,PMC9197876,2022,Jun,13.0
egc_mskcc_2020,stomach,33795256,Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways.,https://cbioportal-datahub.s3.amazonaws.com/egc_mskcc_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33795256,PMC8228505,2021,Jun,15.0
egc_tmucih_2015,egc,25583476,Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.,https://cbioportal-datahub.s3.amazonaws.com/egc_tmucih_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25583476,PMC4313862,2015,Jan,27.0
egc_trap_ccr_msk_2023,egc,37406106,Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.,https://cbioportal-datahub.s3.amazonaws.com/egc_trap_ccr_msk_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37406106,PMC10502449,2023,Sep,15.0
egc_trap_msk_2020,egc,32437664,"First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial.",https://cbioportal-datahub.s3.amazonaws.com/egc_trap_msk_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32437664,PMC8229851,2020,Jun,
es_dfarber_broad_2014,es,25186949,The genomic landscape of pediatric Ewing sarcoma.,https://cbioportal-datahub.s3.amazonaws.com/es_dfarber_broad_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25186949,,2014,Nov,
es_iocurie_2014,es,25223734,Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.,https://cbioportal-datahub.s3.amazonaws.com/es_iocurie_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25223734,PMC4264969,2014,Nov,
escc_icgc,escc,24670651,Identification of genomic alterations in oesophageal squamous cell cancer.,https://cbioportal-datahub.s3.amazonaws.com/escc_icgc.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24670651,,2014,May,1.0
escc_ucla_2014,escc,24686850,Genomic and molecular characterization of esophageal squamous cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/escc_ucla_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24686850,PMC4070589,2014,May,
gbc_msk_2018,gbc,30427539,Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.,https://cbioportal-datahub.s3.amazonaws.com/gbc_msk_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30427539,PMC6636637,2019,Feb,15.0
gbc_mskcc_2022,gbc,36228155,Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention.,https://cbioportal-datahub.s3.amazonaws.com/gbc_mskcc_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36228155,PMC9772093,2022,Dec,15.0
gbc_shanghai_2014,gbc,24997986,Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.,https://cbioportal-datahub.s3.amazonaws.com/gbc_shanghai_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24997986,,2014,Aug,
gbm_columbia_2019,gbm,30742119,Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.,https://cbioportal-datahub.s3.amazonaws.com/gbm_columbia_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30742119,PMC6810613,2019,Mar,
gbm_cptac_2021,gbm,33577785,Proteogenomic and metabolomic characterization of human glioblastoma.,https://cbioportal-datahub.s3.amazonaws.com/gbm_cptac_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33577785,PMC8044053,2021,Apr,12.0
gbm_mayo_pdx_sarkaria_2019,gbm,31852831,Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma.,https://cbioportal-datahub.s3.amazonaws.com/gbm_mayo_pdx_sarkaria_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31852831,PMC7056576,2020,Mar,1.0
gbm_tcga_pub,gbm,18772890,Comprehensive genomic characterization defines human glioblastoma genes and core pathways.,https://cbioportal-datahub.s3.amazonaws.com/gbm_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/18772890,PMC2671642,2008,Oct,23.0
gbm_tcga_pub2013,gbm,24120142,The somatic genomic landscape of glioblastoma.,https://cbioportal-datahub.s3.amazonaws.com/gbm_tcga_pub2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24120142,PMC3910500,2013,Oct,10.0
gct_msk_2016,gct,27646943,Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.,https://cbioportal-datahub.s3.amazonaws.com/gct_msk_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/27646943,PMC5477828,2016,Nov,20.0
gct_msk_2020,testis,32897884,Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor.,https://cbioportal-datahub.s3.amazonaws.com/gct_msk_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32897884,PMC7685753,2020,Dec,1.0
gist_msk_2022,gist,36593350,Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations.,https://cbioportal-datahub.s3.amazonaws.com/gist_msk_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36593350,PMC9807588,2023,Jan,2.0
gist_msk_2023,gist,37477937,Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era.,https://cbioportal-datahub.s3.amazonaws.com/gist_msk_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37477937,PMC11095631,2023,Oct,2.0
glioma_msk_2018,difg,30675060,Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.,https://cbioportal-datahub.s3.amazonaws.com/glioma_msk_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30675060,PMC6457907,2019,Jan,
glioma_mskcc_2019,difg,31263031,Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas.,https://cbioportal-datahub.s3.amazonaws.com/glioma_mskcc_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31263031,PMC6753053,2019,Sep,15.0
hcc_clca_2024,hcc,38355797,Deep whole-genome analysis of 494 hepatocellular carcinomas.,https://cbioportal-datahub.s3.amazonaws.com/hcc_clca_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38355797,,2024,Mar,
hcc_inserm_fr_2015,hcc,25822088,Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.,https://cbioportal-datahub.s3.amazonaws.com/hcc_inserm_fr_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25822088,PMC4587544,2015,May,
hcc_jcopo_msk_2023,hcc,37769223,Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/hcc_jcopo_msk_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37769223,PMC10581608,2023,Sep,
hcc_meric_2021,hcc,35508466,Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages.,https://cbioportal-datahub.s3.amazonaws.com/hcc_meric_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35508466,PMC9068765,2022,May,4.0
hcc_msk_2024,hcc,38864854,A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier.,https://cbioportal-datahub.s3.amazonaws.com/hcc_msk_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38864854,PMC11326964,2024,Aug,15.0
hcc_msk_venturaa_2018,hcc,30052636,Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.,https://cbioportal-datahub.s3.amazonaws.com/hcc_msk_venturaa_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30052636,PMC6063411,2018,,
hcc_mskimpact_2018,hcc,30373752,Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies.,https://cbioportal-datahub.s3.amazonaws.com/hcc_mskimpact_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30373752,PMC6689131,2019,Apr,1.0
hccihch_pku_2019,hccihch,31130341,Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.,https://cbioportal-datahub.s3.amazonaws.com/hccihch_pku_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31130341,PMC8317046,2019,Jun,10.0
hgsoc_msk_2021,hgsoc,34819508,Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors.,https://cbioportal-datahub.s3.amazonaws.com/hgsoc_msk_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34819508,PMC8613272,2021,Nov,24.0
histiocytosis_cobi_msk_2019,hdcn,30867592,Efficacy of MEK inhibition in patients with histiocytic neoplasms.,https://cbioportal-datahub.s3.amazonaws.com/histiocytosis_cobi_msk_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30867592,PMC6438729,2019,Mar,
hnc_mskcc_2016,head_neck,27442865,The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.,https://cbioportal-datahub.s3.amazonaws.com/hnc_mskcc_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/27442865,PMC5253129,2017,Feb,1.0
hnsc_broad,hnsc,21798893,The mutational landscape of head and neck squamous cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/hnsc_broad.tar.gz,https://pubmed.ncbi.nlm.nih.gov/21798893,PMC3415217,2011,Aug,26.0
hnsc_jhu,hnsc,21798897,Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1.,https://cbioportal-datahub.s3.amazonaws.com/hnsc_jhu.tar.gz,https://pubmed.ncbi.nlm.nih.gov/21798897,PMC3162986,2011,Aug,26.0
hnsc_mdanderson_2013,hnsc,23619168,Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers.,https://cbioportal-datahub.s3.amazonaws.com/hnsc_mdanderson_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23619168,PMC3858325,2013,Jul,
hnsc_tcga_pub,hnsc,25631445,Comprehensive genomic characterization of head and neck squamous cell carcinomas.,https://cbioportal-datahub.s3.amazonaws.com/hnsc_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25631445,PMC4311405,2015,Jan,29.0
ihch_ismms_2015,ihch,25608663,Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/ihch_ismms_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25608663,,2015,Jan,22.0
ihch_msk_2021,ihch,33765338,Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/ihch_msk_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33765338,PMC8713028,2021,Sep,
ihch_mskcc_2020,ihch,33963001,Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection.,https://cbioportal-datahub.s3.amazonaws.com/ihch_mskcc_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33963001,PMC8282702,2021,Jul,15.0
ihch_smmu_2014,ihch,25526346,Mutational landscape of intrahepatic cholangiocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/ihch_smmu_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25526346,,2014,Dec,15.0
kich_tcga_pub,chrcc,25155756,The somatic genomic landscape of chromophobe renal cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/kich_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25155756,PMC4160352,2014,Sep,8.0
kirc_bgi,ccrcc,22138691,Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/kirc_bgi.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22138691,,2011,Dec,4.0
kirc_tcga_pub,ccrcc,23792563,Comprehensive molecular characterization of clear cell renal cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/kirc_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23792563,PMC3771322,2013,Jul,4.0
laml_tcga_pub,aml,23634996,Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.,https://cbioportal-datahub.s3.amazonaws.com/laml_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23634996,PMC3767041,2013,May,30.0
lcll_broad_2013,cllsll,23415222,Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.,https://cbioportal-datahub.s3.amazonaws.com/lcll_broad_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23415222,PMC3575604,2013,Feb,14.0
lgg_ucsf_2014,difg,24336570,Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.,https://cbioportal-datahub.s3.amazonaws.com/lgg_ucsf_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24336570,PMC3998672,2014,Jan,10.0
lgggbm_tcga_pub,difg,26824661,Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.,https://cbioportal-datahub.s3.amazonaws.com/lgggbm_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26824661,PMC4754110,2016,Jan,28.0
lgsoc_mapk_msk_2022,lgsoc,35443055,MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/lgsoc_mapk_msk_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35443055,PMC9582036,2022,Oct,14.0
liad_inserm_fr_2014,liad,24735922,Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.,https://cbioportal-datahub.s3.amazonaws.com/liad_inserm_fr_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24735922,,2014,Apr,14.0
lihc_amc_prv,hcc,24798001,Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.,https://cbioportal-datahub.s3.amazonaws.com/lihc_amc_prv.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24798001,,2014,Dec,
lihc_riken,hcc,22634756,Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators.,https://cbioportal-datahub.s3.amazonaws.com/lihc_riken.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22634756,,2012,May,27.0
luad_broad,luad,22980975,Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.,https://cbioportal-datahub.s3.amazonaws.com/luad_broad.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22980975,PMC3557932,2012,Sep,14.0
luad_cptac_2020,luad,32649874,Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/luad_cptac_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32649874,PMC7373300,2020,Jul,9.0
luad_msk_npjpo_2021,luad,34290393,Preoperative clinical and tumor genomic features associated with pathologic lymph node metastasis in clinical stage I and II lung adenocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/luad_msk_npjpo_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34290393,PMC8295366,2021,Jul,21.0
luad_mskcc_2015,luad,25765070,Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.,https://cbioportal-datahub.s3.amazonaws.com/luad_mskcc_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25765070,PMC4993154,2015,Apr,3.0
luad_mskcc_2020,luad,32791233,The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/luad_mskcc_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32791233,PMC7704768,2020,Dec,
luad_mskcc_2023_met_organotropism,luad,37084736,Genomic mapping of metastatic organotropism in lung adenocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/luad_mskcc_2023_met_organotropism.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37084736,PMC10391526,2023,May,8.0
luad_oncosg_2020,luad,32015526,Genomic landscape of lung adenocarcinoma in East Asians.,https://cbioportal-datahub.s3.amazonaws.com/luad_oncosg_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32015526,,2020,Feb,
luad_tcga_pub,luad,25079552,Comprehensive molecular profiling of lung adenocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/luad_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25079552,PMC4231481,2014,Jul,31.0
luad_tsp,luad,18948947,Somatic mutations affect key pathways in lung adenocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/luad_tsp.tar.gz,https://pubmed.ncbi.nlm.nih.gov/18948947,PMC2694412,2008,Oct,23.0
lung_msk_2017,luad,28336552,Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.,https://cbioportal-datahub.s3.amazonaws.com/lung_msk_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28336552,PMC5482929,2017,Jun,
lung_msk_mind_2020,lung,36038778,"Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer.",https://cbioportal-datahub.s3.amazonaws.com/lung_msk_mind_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36038778,PMC9586871,2022,Oct,
lung_nci_2022,luad,34493867,Genomic and evolutionary classification of lung cancer in never smokers.,https://cbioportal-datahub.s3.amazonaws.com/lung_nci_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34493867,PMC8432745,2021,Sep,
lung_pdx_msk_2021,lung,35440124,Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts.,https://cbioportal-datahub.s3.amazonaws.com/lung_pdx_msk_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35440124,PMC9018685,2022,Apr,19.0
lung_smc_2016,lung,27634761,Molecular Evolution Patterns in Metastatic Lymph Nodes Reflect the Differential Treatment Response of Advanced Primary Lung Cancer.,https://cbioportal-datahub.s3.amazonaws.com/lung_smc_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/27634761,,2016,Nov,15.0
lusc_cptac_2021,lusc,34358469,A proteogenomic portrait of lung squamous cell carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/lusc_cptac_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34358469,PMC8475722,2021,Aug,5.0
lusc_tcga_pub,lusc,22960745,Comprehensive genomic characterization of squamous cell lung cancers.,https://cbioportal-datahub.s3.amazonaws.com/lusc_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22960745,PMC3466113,2012,Sep,27.0
lymphoma_cellline_msk_2020,lymph,33067607,Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition.,https://cbioportal-datahub.s3.amazonaws.com/lymphoma_cellline_msk_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33067607,PMC8057264,2021,Apr,15.0
makeanimpact_ccr_2023,mixed,36862133,Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach.,https://cbioportal-datahub.s3.amazonaws.com/makeanimpact_ccr_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36862133,PMC10330105,2023,Jul,5.0
mbc_msk_2021,mbc,33863915,TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.,https://cbioportal-datahub.s3.amazonaws.com/mbc_msk_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33863915,PMC8052452,2021,Apr,16.0
mbl_broad_2012,mbl,22820256,Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.,https://cbioportal-datahub.s3.amazonaws.com/mbl_broad_2012.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22820256,PMC3413789,2012,Aug,2.0
mbl_dkfz_2017,mbl,28726821,The whole-genome landscape of medulloblastoma subtypes.,https://cbioportal-datahub.s3.amazonaws.com/mbl_dkfz_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28726821,PMC5905700,2017,Jul,19.0
mbl_icgc,mbl,22832583,Dissecting the genomic complexity underlying medulloblastoma.,https://cbioportal-datahub.s3.amazonaws.com/mbl_icgc.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22832583,PMC3662966,2012,Aug,2.0
mbl_pcgp,mbl,22722829,Novel mutations target distinct subgroups of medulloblastoma.,https://cbioportal-datahub.s3.amazonaws.com/mbl_pcgp.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22722829,PMC3412905,2012,Aug,2.0
mbl_sickkids_2016,mbl,26760213,Divergent clonal selection dominates medulloblastoma at recurrence.,https://cbioportal-datahub.s3.amazonaws.com/mbl_sickkids_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26760213,PMC4936195,2016,Jan,21.0
mbn_msk_2024,mbn,38497151,Validation of LymphGen classification on a 400-gene clinical next-generation sequencing panel in diffuse large B-cell lymphoma: real-world experience from a cancer center.,https://cbioportal-datahub.s3.amazonaws.com/mbn_msk_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38497151,PMC11215372,2024,Jul,1.0
mbn_sfu_2023,mbn,36201743,Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma.,https://cbioportal-datahub.s3.amazonaws.com/mbn_sfu_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36201743,PMC10023728,2023,Feb,23.0
mcl_idibips_2013,mcl,24145436,Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.,https://cbioportal-datahub.s3.amazonaws.com/mcl_idibips_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24145436,PMC3831489,2013,Nov,5.0
mds_tokyo_2011,mds,21909114,Frequent pathway mutations of splicing machinery in myelodysplasia.,https://cbioportal-datahub.s3.amazonaws.com/mds_tokyo_2011.tar.gz,https://pubmed.ncbi.nlm.nih.gov/21909114,,2011,Sep,11.0
mel_dfci_2019,mel,31792460,Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.,https://cbioportal-datahub.s3.amazonaws.com/mel_dfci_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31792460,PMC6898788,2019,Dec,
mel_mskimpact_2020,mel,33509808,Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas.,https://cbioportal-datahub.s3.amazonaws.com/mel_mskimpact_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33509808,PMC8046739,2021,Apr,15.0
mel_tsam_liang_2017,mel,28373299,Integrated genomic analyses reveal frequent ,https://cbioportal-datahub.s3.amazonaws.com/mel_tsam_liang_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28373299,PMC5378171,2017,Apr,
mel_ucla_2016,mel,26997480,Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.,https://cbioportal-datahub.s3.amazonaws.com/mel_ucla_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26997480,PMC4808437,2016,Mar,24.0
metastatic_solid_tumors_mich_2017,mixed,28783718,Integrative clinical genomics of metastatic cancer.,https://cbioportal-datahub.s3.amazonaws.com/metastatic_solid_tumors_mich_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28783718,PMC5995337,2017,Aug,17.0
mixed_allen_2018,mixed,30150660,Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors.,https://cbioportal-datahub.s3.amazonaws.com/mixed_allen_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30150660,PMC6119118,2018,Sep,
mixed_cfdna_msk_2020,mixed,34059130,Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients.,https://cbioportal-datahub.s3.amazonaws.com/mixed_cfdna_msk_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34059130,PMC8165771,2021,May,31.0
mixed_kunga_msk_2022,mixed,35585047,Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers.,https://cbioportal-datahub.s3.amazonaws.com/mixed_kunga_msk_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35585047,PMC9117241,2022,May,18.0
mixed_msk_tcga_2021,mixed,34635660,Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination.,https://cbioportal-datahub.s3.amazonaws.com/mixed_msk_tcga_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34635660,PMC8505423,2021,Oct,11.0
mixed_pipseq_2017,mixed,28007021,Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.,https://cbioportal-datahub.s3.amazonaws.com/mixed_pipseq_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28007021,PMC5180407,2016,Dec,23.0
mixed_selpercatinib_2020,mixed,35304457,The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.,https://cbioportal-datahub.s3.amazonaws.com/mixed_selpercatinib_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35304457,PMC8933489,2022,Mar,18.0
mm_broad,pcm,24434212,Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.,https://cbioportal-datahub.s3.amazonaws.com/mm_broad.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24434212,PMC4241387,2014,Jan,13.0
mng_utoronto_2021,mng,34433969,A clinically applicable integrative molecular classification of meningiomas.,https://cbioportal-datahub.s3.amazonaws.com/mng_utoronto_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34433969,PMC11604310,2021,Sep,
mnm_washu_2016,mnm,27959731,TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.,https://cbioportal-datahub.s3.amazonaws.com/mnm_washu_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/27959731,PMC5217532,2016,Nov,24.0
mpn_cimr_2013,mpn,24325359,Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.,https://cbioportal-datahub.s3.amazonaws.com/mpn_cimr_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24325359,PMC3966280,2013,Dec,19.0
mpnst_mskcc,mpnst,25240281,PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.,https://cbioportal-datahub.s3.amazonaws.com/mpnst_mskcc.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25240281,PMC4249650,2014,Nov,
mrt_bcgsc_2016,mrt,26977886,Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways.,https://cbioportal-datahub.s3.amazonaws.com/mrt_bcgsc_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26977886,PMC5094835,2016,Mar,14.0
msk_access_2021,mixed,34145282,Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS.,https://cbioportal-datahub.s3.amazonaws.com/msk_access_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34145282,PMC8213710,2021,Jun,18.0
msk_ch_2020,mixed,33106634,Cancer therapy shapes the fitness landscape of clonal hematopoiesis.,https://cbioportal-datahub.s3.amazonaws.com/msk_ch_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33106634,PMC7891089,2020,Nov,
msk_ch_2023,mixed,38147626,High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer.,https://cbioportal-datahub.s3.amazonaws.com/msk_ch_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38147626,PMC10875331,2024,Feb,27.0
msk_ch_ped_2021,mixed,35078859,Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia.,https://cbioportal-datahub.s3.amazonaws.com/msk_ch_ped_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35078859,PMC9983778,2022,Apr,14.0
msk_chord_2024,mixed,39506116,Automated real-world data integration improves cancer outcome prediction.,https://cbioportal-datahub.s3.amazonaws.com/msk_chord_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/39506116,PMC11655358,2024,Dec,
msk_ctdna_vte_2024,mixed,39147831,DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism.,https://cbioportal-datahub.s3.amazonaws.com/msk_ctdna_vte_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/39147831,PMC11405286,2024,Sep,
msk_impact_2017,mixed,28481359,"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.",https://cbioportal-datahub.s3.amazonaws.com/msk_impact_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28481359,PMC5461196,2017,Jun,
msk_met_2021,mixed,35120664,"Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients.",https://cbioportal-datahub.s3.amazonaws.com/msk_met_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35120664,PMC9147702,2022,Feb,3.0
msk_spectrum_tme_2022,hgsoc,36517593,Ovarian cancer mutational processes drive site-specific immune evasion.,https://cbioportal-datahub.s3.amazonaws.com/msk_spectrum_tme_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36517593,PMC9771812,2022,Dec,
mtnn_msk_2022,mtnn,37078708,TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.,https://cbioportal-datahub.s3.amazonaws.com/mtnn_msk_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37078708,PMC10480533,2023,Sep,12.0
nbl_amc_2012,nbl,22367537,Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.,https://cbioportal-datahub.s3.amazonaws.com/nbl_amc_2012.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22367537,,2012,Feb,22.0
nbl_broad_2013,nbl,23334666,The genetic landscape of high-risk neuroblastoma.,https://cbioportal-datahub.s3.amazonaws.com/nbl_broad_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23334666,PMC3682833,2013,Mar,
nbl_ucologne_2015,nbl,26466568,Telomerase activation by genomic rearrangements in high-risk neuroblastoma.,https://cbioportal-datahub.s3.amazonaws.com/nbl_ucologne_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26466568,PMC4881306,2015,Oct,29.0
nccrcc_genentech_2014,nccrcc,25401301,Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.,https://cbioportal-datahub.s3.amazonaws.com/nccrcc_genentech_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25401301,PMC4489427,2015,Jan,
nepc_wcm_2016,prad,26855148,Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.,https://cbioportal-datahub.s3.amazonaws.com/nepc_wcm_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26855148,PMC4777652,2016,Mar,
nhl_bcgsc_2011,nhl,21796119,Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.,https://cbioportal-datahub.s3.amazonaws.com/nhl_bcgsc_2011.tar.gz,https://pubmed.ncbi.nlm.nih.gov/21796119,PMC3210554,2011,Jul,27.0
nhl_bcgsc_2013,nhl,23699601,Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.,https://cbioportal-datahub.s3.amazonaws.com/nhl_bcgsc_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23699601,PMC3744992,2013,Aug,15.0
npc_nusingapore,npc,24952746,The genomic landscape of nasopharyngeal carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/npc_nusingapore.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24952746,,2014,Aug,
nsclc_ctdx_msk_2022,nsclc,36357680,Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.,https://cbioportal-datahub.s3.amazonaws.com/nsclc_ctdx_msk_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36357680,PMC10338177,2022,Nov,
nsclc_mskcc_2015,nsclc,25765070,Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.,https://cbioportal-datahub.s3.amazonaws.com/nsclc_mskcc_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25765070,PMC4993154,2015,Apr,3.0
nsclc_mskcc_2018,nsclc,29657128,Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.,https://cbioportal-datahub.s3.amazonaws.com/nsclc_mskcc_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29657128,PMC5953836,2018,May,14.0
nsclc_pd1_msk_2018,nsclc,29337640,Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.,https://cbioportal-datahub.s3.amazonaws.com/nsclc_pd1_msk_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29337640,PMC6075848,2018,Mar,1.0
nsclc_tcga_broad_2016,nsclc,27158780,Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.,https://cbioportal-datahub.s3.amazonaws.com/nsclc_tcga_broad_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/27158780,PMC4884143,2016,Jun,
nsclc_unito_2016,nsclc,27346245,Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research.,https://cbioportal-datahub.s3.amazonaws.com/nsclc_unito_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/27346245,,2017,May,
nst_nfosi_ntap,nst,32561749,A clinically and genomically annotated nerve sheath tumor biospecimen repository.,https://cbioportal-datahub.s3.amazonaws.com/nst_nfosi_ntap.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32561749,PMC7305302,2020,Jun,19.0
ntrk_msk_2019,mixed,31871300,TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations.,https://cbioportal-datahub.s3.amazonaws.com/ntrk_msk_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31871300,PMC7124988,2020,Apr,1.0
odg_msk_2017,aodg,28472509,Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.,https://cbioportal-datahub.s3.amazonaws.com/odg_msk_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28472509,PMC5596171,2017,Oct,1.0
ov_tcga_pub,hgsoc,21720365,Integrated genomic analyses of ovarian carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/ov_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/21720365,PMC3163504,2011,Jun,29.0
paac_jhu_2014,paac,24293293,Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.,https://cbioportal-datahub.s3.amazonaws.com/paac_jhu_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24293293,PMC4048021,2014,Mar,
paad_cptac_2021,paad,34534465,Proteogenomic characterization of pancreatic ductal adenocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/paad_cptac_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34534465,PMC8654574,2021,Sep,16.0
paad_icgc,paad,23103869,Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.,https://cbioportal-datahub.s3.amazonaws.com/paad_icgc.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23103869,PMC3530898,2012,Nov,15.0
paad_qcmg_uq_2016,paad,26909576,Genomic analyses identify molecular subtypes of pancreatic cancer.,https://cbioportal-datahub.s3.amazonaws.com/paad_qcmg_uq_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26909576,,2016,Mar,3.0
paad_utsw_2015,paad,25855536,Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.,https://cbioportal-datahub.s3.amazonaws.com/paad_utsw_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25855536,PMC4403382,2015,Apr,9.0
pact_jhu_2011,pact,22158988,Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.,https://cbioportal-datahub.s3.amazonaws.com/pact_jhu_2011.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22158988,PMC3248495,2011,Dec,27.0
paired_bladder_2022,bladder,36543146,Genomic heterogeneity as a barrier to precision oncology in urothelial cancer.,https://cbioportal-datahub.s3.amazonaws.com/paired_bladder_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36543146,PMC9882421,2022,Dec,20.0
pan_origimed_2020,mixed,35871175,Landscape of somatic alterations in large-scale solid tumors from an Asian population.,https://cbioportal-datahub.s3.amazonaws.com/pan_origimed_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35871175,PMC9308789,2022,Jul,23.0
pancan_mappyacts_2022,mixed,35292802,The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies.,https://cbioportal-datahub.s3.amazonaws.com/pancan_mappyacts_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35292802,PMC9394403,2022,May,2.0
pancan_pcawg_2020,mixed,32025007,Pan-cancer analysis of whole genomes.,https://cbioportal-datahub.s3.amazonaws.com/pancan_pcawg_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32025007,PMC7025898,2020,Feb,
pancreas_msk_2024,pancreas,39214094,Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer.,https://cbioportal-datahub.s3.amazonaws.com/pancreas_msk_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/39214094,PMC11419252,2024,Sep,9.0
panet_arcnet_2017,panet,28199314,Whole-genome landscape of pancreatic neuroendocrine tumours.,https://cbioportal-datahub.s3.amazonaws.com/panet_arcnet_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28199314,,2017,Mar,2.0
panet_jhu_2011,panet,21252315,"DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.",https://cbioportal-datahub.s3.amazonaws.com/panet_jhu_2011.tar.gz,https://pubmed.ncbi.nlm.nih.gov/21252315,PMC3144496,2011,Mar,4.0
panet_msk_2018,panet,30687805,Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability.,https://cbioportal-datahub.s3.amazonaws.com/panet_msk_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30687805,PMC6345401,2018,,
panet_shanghai_2013,panet,24326773,Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1.,https://cbioportal-datahub.s3.amazonaws.com/panet_shanghai_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24326773,,2013,,
past_dkfz_heidelberg_2013,past,23817572,Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.,https://cbioportal-datahub.s3.amazonaws.com/past_dkfz_heidelberg_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23817572,PMC3951336,2013,Aug,
pcnsl_mayo_2015,nhl,25991819,Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.,https://cbioportal-datahub.s3.amazonaws.com/pcnsl_mayo_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25991819,PMC4558226,2015,Sep,1.0
pcnsl_msk_2024,pcnsl,38995739,A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma.,https://cbioportal-datahub.s3.amazonaws.com/pcnsl_msk_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38995739,PMC11398981,2024,Sep,13.0
pcpg_tcga_pub,soft_tissue,28162975,Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.,https://cbioportal-datahub.s3.amazonaws.com/pcpg_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28162975,PMC5643159,2017,Feb,13.0
pediatric_dkfz_2017,mixed,29489754,The landscape of genomic alterations across childhood cancers.,https://cbioportal-datahub.s3.amazonaws.com/pediatric_dkfz_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29489754,,2018,Mar,15.0
plmeso_msk_2024,plmeso,38630790,"Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features.",https://cbioportal-datahub.s3.amazonaws.com/plmeso_msk_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38630790,PMC11216861,2024,Jul,1.0
plmeso_nyu_2015,plmeso,25488749,"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.",https://cbioportal-datahub.s3.amazonaws.com/plmeso_nyu_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25488749,,2015,Jan,15.0
pog570_bcgsc_2020,mixed,35121966,Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes.,https://cbioportal-datahub.s3.amazonaws.com/pog570_bcgsc_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35121966,,2020,Apr,
pptc_2019,mixed,31693904,Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.,https://cbioportal-datahub.s3.amazonaws.com/pptc_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31693904,PMC6880934,2019,Nov,5.0
prad_broad,prad,22610119,"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.",https://cbioportal-datahub.s3.amazonaws.com/prad_broad.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22610119,PMC3673022,2012,May,20.0
prad_broad_2013,prad,23622249,Punctuated evolution of prostate cancer genomes.,https://cbioportal-datahub.s3.amazonaws.com/prad_broad_2013.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23622249,PMC3690918,2013,Apr,25.0
prad_cdk12_mskcc_2020,prad,32317181,Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics.,https://cbioportal-datahub.s3.amazonaws.com/prad_cdk12_mskcc_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32317181,PMC7572747,2020,Nov,
prad_cpcg_2017,prad,28068672,"Genomic hallmarks of localized, non-indolent prostate cancer.",https://cbioportal-datahub.s3.amazonaws.com/prad_cpcg_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28068672,,2017,Jan,19.0
prad_eururol_2017,prad,28927585,Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.,https://cbioportal-datahub.s3.amazonaws.com/prad_eururol_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28927585,,2018,Mar,
prad_fhcrc,prad,26928463,Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.,https://cbioportal-datahub.s3.amazonaws.com/prad_fhcrc.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26928463,PMC5045679,2016,Apr,
prad_mcspc_mskcc_2020,prad,32220891,"Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer.",https://cbioportal-datahub.s3.amazonaws.com/prad_mcspc_mskcc_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32220891,PMC7334067,2020,Jul,1.0
prad_mich,prad,22722839,The mutational landscape of lethal castration-resistant prostate cancer.,https://cbioportal-datahub.s3.amazonaws.com/prad_mich.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22722839,PMC3396711,2012,Jul,12.0
prad_msk_2019,prostate,31564440,Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1.,https://cbioportal-datahub.s3.amazonaws.com/prad_msk_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31564440,PMC6949382,2020,Jan,7.0
prad_msk_mdanderson_2023,prostate,38488813,Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.,https://cbioportal-datahub.s3.amazonaws.com/prad_msk_mdanderson_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38488813,PMC11094415,2024,May,15.0
prad_msk_stopsack_2021,prad,34667026,"Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors.",https://cbioportal-datahub.s3.amazonaws.com/prad_msk_stopsack_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/34667026,PMC8776579,2022,Jan,15.0
prad_mskcc,prad,20579941,Integrative genomic profiling of human prostate cancer.,https://cbioportal-datahub.s3.amazonaws.com/prad_mskcc.tar.gz,https://pubmed.ncbi.nlm.nih.gov/20579941,PMC3198787,2010,Jul,13.0
prad_mskcc_2014,prad,25024180,Copy number alteration burden predicts prostate cancer relapse.,https://cbioportal-datahub.s3.amazonaws.com/prad_mskcc_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25024180,PMC4121784,2014,Jul,29.0
prad_mskcc_2017,prad,28825054,Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.,https://cbioportal-datahub.s3.amazonaws.com/prad_mskcc_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28825054,PMC5558263,2017,Jul,
prad_mskcc_cheny1_organoids_2014,prad,25201530,Organoid cultures derived from patients with advanced prostate cancer.,https://cbioportal-datahub.s3.amazonaws.com/prad_mskcc_cheny1_organoids_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25201530,PMC4237931,2014,Sep,25.0
prad_organoids_msk_2022,prad,35617398,Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.,https://cbioportal-datahub.s3.amazonaws.com/prad_organoids_msk_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35617398,PMC9299269,2022,May,27.0
prad_p1000,prad,29610475,The long tail of oncogenic drivers in prostate cancer.,https://cbioportal-datahub.s3.amazonaws.com/prad_p1000.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29610475,PMC6107367,2018,May,
prad_pik3r1_msk_2021,prad,35670774,The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate Cancer.,https://cbioportal-datahub.s3.amazonaws.com/prad_pik3r1_msk_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35670774,PMC9438279,2022,Aug,15.0
prad_su2c_2015,prad,26000489,Integrative clinical genomics of advanced prostate cancer.,https://cbioportal-datahub.s3.amazonaws.com/prad_su2c_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26000489,PMC4484602,2015,May,21.0
prad_su2c_2019,prad,31061129,Genomic correlates of clinical outcome in advanced prostate cancer.,https://cbioportal-datahub.s3.amazonaws.com/prad_su2c_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31061129,PMC6561293,2019,Jun,4.0
prad_tcga_pub,prad,26544944,The Molecular Taxonomy of Primary Prostate Cancer.,https://cbioportal-datahub.s3.amazonaws.com/prad_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26544944,PMC4695400,2015,Nov,5.0
prostate_dkfz_2018,prostate,30537516,Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.,https://cbioportal-datahub.s3.amazonaws.com/prostate_dkfz_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30537516,PMC7444093,2018,Dec,10.0
prostate_msk_2024,prostate,38949888,"Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer.",https://cbioportal-datahub.s3.amazonaws.com/prostate_msk_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38949888,PMC11371520,2024,Sep,3.0
prostate_pcbm_swiss_2019,prostate,35504881,Alterations in homologous recombination repair genes in prostate cancer brain metastases.,https://cbioportal-datahub.s3.amazonaws.com/prostate_pcbm_swiss_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35504881,PMC9065149,2022,May,3.0
ptad_msk_2024,ptad,38758238,"Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.",https://cbioportal-datahub.s3.amazonaws.com/ptad_msk_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38758238,PMC11101347,2024,May,17.0
rbl_cfdna_msk_2020,rbl,32633890,Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience.,https://cbioportal-datahub.s3.amazonaws.com/rbl_cfdna_msk_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32633890,PMC7476838,2020,Sep,
rbl_mskcc_2020,rbl,33466343,Molecular Changes in Retinoblastoma beyond ,https://cbioportal-datahub.s3.amazonaws.com/rbl_mskcc_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33466343,PMC7796332,2021,Jan,5.0
rectal_msk_2019,coadread,31591597,A rectal cancer organoid platform to study individual responses to chemoradiation.,https://cbioportal-datahub.s3.amazonaws.com/rectal_msk_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31591597,PMC7385919,2019,Oct,
rectal_msk_2022,bowel,35970919,Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer.,https://cbioportal-datahub.s3.amazonaws.com/rectal_msk_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35970919,PMC9801308,2022,Aug,
rms_msk_2023,rms,37315267,Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.,https://cbioportal-datahub.s3.amazonaws.com/rms_msk_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37315267,PMC10309566,2023,Jun,
rms_nih_2014,rms,24436047,Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.,https://cbioportal-datahub.s3.amazonaws.com/rms_nih_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24436047,PMC4462130,2014,Feb,
sarc_mskcc,soft_tissue,20601955,Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.,https://cbioportal-datahub.s3.amazonaws.com/sarc_mskcc.tar.gz,https://pubmed.ncbi.nlm.nih.gov/20601955,PMC2911503,2010,Aug,
sarc_tcga_pub,soft_tissue,29100075,Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.,https://cbioportal-datahub.s3.amazonaws.com/sarc_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29100075,PMC5693358,2017,Nov,2.0
sarcoma_msk_2022,soft_tissue,35705558,Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.,https://cbioportal-datahub.s3.amazonaws.com/sarcoma_msk_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35705558,PMC9200814,2022,Jun,15.0
sarcoma_msk_2023,mixed,37350195,Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.,https://cbioportal-datahub.s3.amazonaws.com/sarcoma_msk_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37350195,PMC10756077,2023,Aug,
sarcoma_mskcc_2022,soft_tissue,35705560,Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets.,https://cbioportal-datahub.s3.amazonaws.com/sarcoma_mskcc_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35705560,PMC9200818,2022,Jun,15.0
scco_mskcc,scco,24658004,Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.,https://cbioportal-datahub.s3.amazonaws.com/scco_mskcc.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24658004,PMC5699446,2014,May,
sclc_cancercell_gardner_2017,sclc,28196596,Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.,https://cbioportal-datahub.s3.amazonaws.com/sclc_cancercell_gardner_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28196596,PMC5313262,2017,Feb,13.0
sclc_clcgp,sclc,22941188,Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.,https://cbioportal-datahub.s3.amazonaws.com/sclc_clcgp.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22941188,PMC4915822,2012,Oct,
sclc_jhu,sclc,22941189,Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.,https://cbioportal-datahub.s3.amazonaws.com/sclc_jhu.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22941189,PMC3557461,2012,Oct,
sclc_ucologne_2015,sclc,26168399,Comprehensive genomic profiles of small cell lung cancer.,https://cbioportal-datahub.s3.amazonaws.com/sclc_ucologne_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26168399,PMC4861069,2015,Aug,6.0
skcm_broad,skcm,22817889,A landscape of driver mutations in melanoma.,https://cbioportal-datahub.s3.amazonaws.com/skcm_broad.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22817889,PMC3600117,2012,Jul,20.0
skcm_broad_brafresist_2012,mel,24265153,The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma.,https://cbioportal-datahub.s3.amazonaws.com/skcm_broad_brafresist_2012.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24265153,PMC3947264,2014,Jan,
skcm_broad_dfarber,skcm,22622578,Melanoma genome sequencing reveals frequent PREX2 mutations.,https://cbioportal-datahub.s3.amazonaws.com/skcm_broad_dfarber.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22622578,PMC3367798,2012,May,9.0
skcm_dfci_2015,skcm,26359337,Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.,https://cbioportal-datahub.s3.amazonaws.com/skcm_dfci_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26359337,PMC5054517,2015,Oct,9.0
skcm_mskcc_2014,skcm,25409260,Genetic basis for clinical response to CTLA-4 blockade in melanoma.,https://cbioportal-datahub.s3.amazonaws.com/skcm_mskcc_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25409260,PMC4315319,2014,Dec,4.0
skcm_tcga_pub_2015,skcm,26091043,Genomic Classification of Cutaneous Melanoma.,https://cbioportal-datahub.s3.amazonaws.com/skcm_tcga_pub_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26091043,PMC4580370,2015,Jun,18.0
skcm_vanderbilt_mskcc_2015,skcm,32913971,,https://cbioportal-datahub.s3.amazonaws.com/skcm_vanderbilt_mskcc_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32913971,PMC7446400,2017,,
skcm_yale,skcm,22842228,Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.,https://cbioportal-datahub.s3.amazonaws.com/skcm_yale.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22842228,PMC3432702,2012,Sep,
soft_tissue_msk_2023,rms,37730754,Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse.,https://cbioportal-datahub.s3.amazonaws.com/soft_tissue_msk_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37730754,PMC10511463,2023,Sep,20.0
stad_oncosg_2018,stad,29670109,Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.,https://cbioportal-datahub.s3.amazonaws.com/stad_oncosg_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29670109,PMC5906695,2018,Apr,18.0
stad_pfizer_uhongkong,stad,24816253,Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.,https://cbioportal-datahub.s3.amazonaws.com/stad_pfizer_uhongkong.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24816253,,2014,Jun,
stad_tcga_pub,stad,25079317,Comprehensive molecular characterization of gastric adenocarcinoma.,https://cbioportal-datahub.s3.amazonaws.com/stad_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25079317,PMC4170219,2014,Sep,11.0
stad_uhongkong,stad,22037554,Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.,https://cbioportal-datahub.s3.amazonaws.com/stad_uhongkong.tar.gz,https://pubmed.ncbi.nlm.nih.gov/22037554,,2011,Oct,30.0
stad_utokyo,stad,24816255,Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/stad_utokyo.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24816255,,2014,Jun,
stes_tcga_pub,egc,28052061,Integrated genomic characterization of oesophageal carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/stes_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28052061,PMC5651175,2017,Jan,12.0
stmyec_wcm_2022,stmyec,36577525,Whole-genome characterization of myoepithelial carcinomas of the soft tissue.,https://cbioportal-datahub.s3.amazonaws.com/stmyec_wcm_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36577525,PMC9808553,2022,Dec,
summit_2018,mixed,29420467,HER kinase inhibition in patients with HER2- and HER3-mutant cancers.,https://cbioportal-datahub.s3.amazonaws.com/summit_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29420467,PMC5808581,2018,Feb,8.0
tet_nci_2014,tet,24974848,A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.,https://cbioportal-datahub.s3.amazonaws.com/tet_nci_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/24974848,PMC5705185,2014,Aug,
thca_tcga_pub,thpa,25417114,Integrated genomic characterization of papillary thyroid carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/thca_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25417114,PMC4243044,2014,Oct,23.0
thyroid_gatci_2024,thyroid,38412093,The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/thyroid_gatci_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38412093,PMC11077417,2024,Mar,26.0
thyroid_mskcc_2016,thyroid,26878173,Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.,https://cbioportal-datahub.s3.amazonaws.com/thyroid_mskcc_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26878173,PMC4767360,2016,Mar,1.0
tmb_mskcc_2018,mixed,30643254,Tumor mutational load predicts survival after immunotherapy across multiple cancer types.,https://cbioportal-datahub.s3.amazonaws.com/tmb_mskcc_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30643254,PMC6365097,2019,Feb,
uccc_nih_2017,uccc,28485815,Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.,https://cbioportal-datahub.s3.amazonaws.com/uccc_nih_2017.tar.gz,https://pubmed.ncbi.nlm.nih.gov/28485815,PMC5587124,2017,Sep,1.0
ucec_ancestry_cds_msk_2023,ucec,37651310,Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications.,https://cbioportal-datahub.s3.amazonaws.com/ucec_ancestry_cds_msk_2023.tar.gz,https://pubmed.ncbi.nlm.nih.gov/37651310,PMC11149479,2023,Nov,1.0
ucec_ccr_cfdna_msk_2022,ucec,36007103,High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer.,https://cbioportal-datahub.s3.amazonaws.com/ucec_ccr_cfdna_msk_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/36007103,PMC9852004,2023,Jan,17.0
ucec_ccr_msk_2022,ucec,35849120,Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.,https://cbioportal-datahub.s3.amazonaws.com/ucec_ccr_msk_2022.tar.gz,https://pubmed.ncbi.nlm.nih.gov/35849120,PMC9529954,2022,Oct,3.0
ucec_cptac_2020,ucec,32059776,Proteogenomic Characterization of Endometrial Carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/ucec_cptac_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32059776,PMC7233456,2020,Feb,20.0
ucec_msk_2018,ucec,30068706,Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer.,https://cbioportal-datahub.s3.amazonaws.com/ucec_msk_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/30068706,PMC6279519,2018,Dec,1.0
ucec_msk_2024,mixed,38653864,Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.,https://cbioportal-datahub.s3.amazonaws.com/ucec_msk_2024.tar.gz,https://pubmed.ncbi.nlm.nih.gov/38653864,PMC11108776,2024,May,
ucec_tcga_pub,ucec,23636398,Integrated genomic characterization of endometrial carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/ucec_tcga_pub.tar.gz,https://pubmed.ncbi.nlm.nih.gov/23636398,PMC3704730,2013,May,2.0
ucs_jhu_2014,ucs,25233892,Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes.,https://cbioportal-datahub.s3.amazonaws.com/ucs_jhu_2014.tar.gz,https://pubmed.ncbi.nlm.nih.gov/25233892,PMC4354107,2014,Sep,19.0
um_qimr_2016,um,26683228,Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.,https://cbioportal-datahub.s3.amazonaws.com/um_qimr_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26683228,PMC4826231,2016,Jan,26.0
urcc_mskcc_2016,urcc,27713405,Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.,https://cbioportal-datahub.s3.amazonaws.com/urcc_mskcc_2016.tar.gz,https://pubmed.ncbi.nlm.nih.gov/27713405,PMC5059781,2016,Oct,7.0
usarc_msk_2020,usarc,32299819,Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing.,https://cbioportal-datahub.s3.amazonaws.com/usarc_msk_2020.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32299819,PMC7367750,2020,Jul,15.0
utuc_cornell_baylor_mdacc_2019,utuc,31278255,Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling.,https://cbioportal-datahub.s3.amazonaws.com/utuc_cornell_baylor_mdacc_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/31278255,PMC6611775,2019,Jul,5.0
utuc_igbmc_2021,utuc,33397444,Comprehensive integrative profiling of upper tract urothelial carcinomas.,https://cbioportal-datahub.s3.amazonaws.com/utuc_igbmc_2021.tar.gz,https://pubmed.ncbi.nlm.nih.gov/33397444,PMC7780630,2021,Jan,4.0
utuc_msk_2019,utuc,32332851,Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts.,https://cbioportal-datahub.s3.amazonaws.com/utuc_msk_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32332851,PMC7181640,2020,Apr,24.0
utuc_mskcc_2015,utuc,26278805,Genomic Characterization of Upper Tract Urothelial Carcinoma.,https://cbioportal-datahub.s3.amazonaws.com/utuc_mskcc_2015.tar.gz,https://pubmed.ncbi.nlm.nih.gov/26278805,PMC4675454,2015,Dec,
utuc_pdx_msk_2019,utuc,32332851,Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts.,https://cbioportal-datahub.s3.amazonaws.com/utuc_pdx_msk_2019.tar.gz,https://pubmed.ncbi.nlm.nih.gov/32332851,PMC7181640,2020,Apr,24.0
vsc_cuk_2018,vsc,29422544,Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva.,https://cbioportal-datahub.s3.amazonaws.com/vsc_cuk_2018.tar.gz,https://pubmed.ncbi.nlm.nih.gov/29422544,PMC5903820,2018,Feb,9.0
